Funding, News and Announcements
» Go to news mainPfizer Research Grant RFP: Transthyretin Amyloid Cardiomyopathy (ATTR‑CM) Research in Canada
Posted by Jaq-Lin Larder on
July 10, 2023
in
Research Funding
Pfizer is interested in supporting proposals that advance our understanding of the basic science and early diagnosis and treatment of ATTR cardiac amyloidosis through research.
Individual projects requesting up to $100,000 CAD will be considered.
Full call details are available here.
Internal Deadline: September 19, 2023 at 4:30pm. Contact email is ird@Dal.ca.
Funder Deadline: October 2, 2023